BTG ' s PE Device Works Faster and at Lower Doses in Study BTG ' s PE Device Works Faster and at Lower Doses in Study

British pharmaceutical firm BTG said its EKOS combination therapy device for pulmonary embolism (PE) was effective using smaller drug dosages and shorter treatment periods than the current standard.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Pulmonary Medicine News Source Type: news